Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Businessweek Archives

The Fda May Be In Hot Water Again


In Business This Week

THE FDA MAY BE IN HOT WATER AGAIN

Just as the Food & Drug Administration is beginning to recover from the generic-drug scandals of 1988, the agency may be heading for another disgrace. A federal grand jury in Baltimore is investigating charges that FDA officials passed confidential information about coming drug approvals to brokerage firms in return for cash. Approval for a major drug often sends the stock of its maker soaring. An FDA spokesman admits that several employees have been subpoenaed but says that the agency has no evidence of wrongdoing.EDITED BY HARRIS COLLINGWOOD


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus